Payment overview · 2025
General Payments
$83.19
4 reported records · 3 companies
Healthcare provider profile · identity verified
Larry Saul Kramer, DO
Allopathic & Osteopathic Physicians|Family Medicine · PHILA, PA · NPI 1407830086
Verified facts
What the public records show
CMS Open Payments records show Larry Saul Kramer, DO received $83.19 in general payments during 2025 across 4 reported records.
PFIZER INC. accounted for 44.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Trelegy Ellipta by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 110 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $36.83 | 44.3% | 2 | 2025 |
| SANOFI PASTEUR INC. | Unresolved — no canonical attribution shown | $28.50 | 34.3% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $17.86 | 21.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $83.19 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $36.83 | 2 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $36.83 | 2 | 2025 |
Source payment records
|
|||||
| FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE Normalized: flublok quadrivalent northern hemisphere |
Biological | SANOFI PASTEUR INC. | $28.50 | 1 | 2025 |
Source payment records
|
|||||
| FLUZONE HIGH-DOSE Normalized: fluzone high dose |
Biological | SANOFI PASTEUR INC. | $28.50 | 1 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $17.86 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $17.86 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 110 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
51 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
110 | 16 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 842 | 190 |
| Amlodipine Besylate | Amlodipine Besylate | 553 | 112 |
| Metformin Hcl | Metformin Hcl | 533 | 124 |
| Losartan Potassium | Losartan Potassium | 469 | 103 |
| Lisinopril | Lisinopril | 400 | 93 |
| Levothyroxine Sodium | Levothyroxine Sodium | 380 | 80 |
| Pantoprazole Sodium | Pantoprazole Sodium | 317 | 73 |
| Gabapentin | Gabapentin | 287 | 56 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 284 | 49 |
| Omeprazole | Omeprazole | 272 | 62 |
| Diclofenac Sodium | Diclofenac Sodium | 266 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 256 | 52 |
| Simvastatin | Simvastatin | 209 | 48 |
| Fluticasone Propionate | Fluticasone Propionate | 191 | 46 |
| Furosemide | Furosemide | 187 | 38 |
| Glimepiride | Glimepiride | 181 | 43 |
| Hydrochlorothiazide | Hydrochlorothiazide | 164 | 41 |
| Lorazepam | Lorazepam | 159 | 34 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 152 | 37 |
| Metoprolol Succinate | Metoprolol Succinate | 146 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 131 | 25 |
| Famotidine | Famotidine | 127 | 29 |
| Januvia | Sitagliptin Phosphate | 127 | 28 |
| Montelukast Sodium | Montelukast Sodium | 127 | 24 |
| Trazodone Hcl | Trazodone Hcl | 126 | 22 |
| Allopurinol | Allopurinol | 113 | 23 |
| Eliquis | Apixaban | 110 | 16 |
| Ibuprofen | Ibuprofen | 108 | 23 |
| Tamsulosin Hcl | Tamsulosin Hcl | 105 | 26 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 98 | 13 |
| Alendronate Sodium | Alendronate Sodium | 96 | 19 |
| Donepezil Hcl | Donepezil Hcl | 82 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 82 | 22 |
| Sertraline Hcl | Sertraline Hcl | 82 | 20 |
| Atenolol | Atenolol | 80 | 16 |
| Trulicity | Dulaglutide | 80 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 78 | 22 |
| Amoxicillin | Amoxicillin | 77 | 58 |
| Ezetimibe | Ezetimibe | 76 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 76 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 76 | suppressed |
| Lovastatin | Lovastatin | 75 | 18 |
| Naproxen | Naproxen | 75 | 14 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 68 | 11 |
| Azithromycin | Azithromycin | 67 | 51 |
| Ipratropium Bromide | Ipratropium Bromide | 65 | 13 |
| Alprazolam | Alprazolam | 64 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 64 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 63 | 15 |
| Carvedilol | Carvedilol | 61 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 59 | 14 |
| Spironolactone | Spironolactone | 57 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 55 | 11 |
| Buspirone Hcl | Buspirone Hcl | 53 | suppressed |
| Meloxicam | Meloxicam | 53 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 51 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 50 | 14 |
| Diazepam | Diazepam | 49 | suppressed |
| Potassium Chloride | Potassium Chloride | 48 | suppressed |
| Baclofen | Baclofen | 42 | suppressed |
| Jardiance | Empagliflozin | 41 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 40 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 39 | suppressed |
| Fluocinonide | Fluocinonide | 39 | 15 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 39 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 39 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 39 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 38 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 36 | 13 |
| Xarelto | Rivaroxaban | 36 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 35 | suppressed |
| Lansoprazole | Lansoprazole | 35 | suppressed |
| Fluconazole | Fluconazole | 34 | suppressed |
| Mupirocin | Mupirocin | 34 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 33 | suppressed |
| Linzess | Linaclotide | 33 | suppressed |
| Eszopiclone | Eszopiclone | 32 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 32 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 32 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 32 | suppressed |
| Synthroid | Levothyroxine Sodium | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | suppressed |
| Celecoxib | Celecoxib | 29 | suppressed |
| Glipizide | Glipizide | 29 | suppressed |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Clonazepam | Clonazepam | 28 | suppressed |
| Latanoprost | Latanoprost | 28 | suppressed |
| Pregabalin | Pregabalin | 28 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 28 | suppressed |
| Vascepa | Icosapent Ethyl | 28 | suppressed |
| Prednisone | Prednisone | 27 | 15 |
| Bumetanide | Bumetanide | 26 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 26 | suppressed |
| Desloratadine | Desloratadine | 24 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 24 | suppressed |
| Mirtazapine | Mirtazapine | 24 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | 23 |
| Zaleplon | Zaleplon | 24 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 23 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 23 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 23 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 22 | suppressed |
| Loperamide | Loperamide Hcl | 22 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 21 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 20 | suppressed |
| Tradjenta | Linagliptin | 20 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Entresto | Sacubitril/Valsartan | 19 | suppressed |
| Humulin R U-500 Kwikpen | Insulin Regular, Human | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Pulmicort Flexhaler | Budesonide | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 19 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 18 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Bupropion Xl | Bupropion Hcl | 17 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 17 | suppressed |
| Finasteride | Finasteride | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 16 | suppressed |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 16 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 15 | suppressed |
| Easy Comfort Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Erythromycin | Erythromycin Base | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Ciclopirox | Ciclopirox | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 13 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 13 | suppressed |
| Alyacen | Norethindrone-Ethin. Estradiol | 12 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Multaq | Dronedarone Hcl | 12 | suppressed |
| Nateglinide | Nateglinide | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Brilinta | Ticagrelor | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 11 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Zonisamide | Zonisamide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $83.19 · 4 records | PFIZER INC. | AREXVY, ELIQUIS, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE HIGH-DOSE, NURTEC ODT, SHINGRIX | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error